rs547150342

Variant summary

Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5

The ENST00000389817.8(ABCC8):​c.2522G>A​(p.Arg841Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,611,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R841G) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

ABCC8
ENST00000389817.8 missense

Scores

14
4
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4U:1O:2

Conservation

PhyloP100: 7.89
Variant links:
Genes affected
ABCC8 (HGNC:59): (ATP binding cassette subfamily C member 8) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions as a modulator of ATP-sensitive potassium channels and insulin release. Mutations in the ABCC8 gene and deficiencies in the encoded protein have been observed in patients with hyperinsulinemic hypoglycemia of infancy, an autosomal recessive disorder of unregulated and high insulin secretion. Mutations have also been associated with non-insulin-dependent diabetes mellitus type II, an autosomal dominant disease of defective insulin secretion. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 11 ACMG points.

PM1
In a helix (size 11) in uniprot entity ABCC8_HUMAN there are 5 pathogenic changes around while only 1 benign (83%) in ENST00000389817.8
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-17412701-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1489024.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=1}.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.989
PP5
Variant 11-17412700-C-T is Pathogenic according to our data. Variant chr11-17412700-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 554121.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=3, Pathogenic=1, Uncertain_significance=1, Uncertain_risk_allele=2}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ABCC8NM_000352.6 linkuse as main transcriptc.2522G>A p.Arg841Gln missense_variant 21/39 ENST00000389817.8 NP_000343.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ABCC8ENST00000389817.8 linkuse as main transcriptc.2522G>A p.Arg841Gln missense_variant 21/391 NM_000352.6 ENSP00000374467 P4Q09428-1

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152020
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000206
AC:
3
AN:
1459786
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
725882
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000117
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.00e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152138
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74384
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:1Other:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hyperinsulinemic hypoglycemia, familial, 1 Pathogenic:2Uncertain:1
Likely pathogenic, criteria provided, single submitterclinical testingDiagnostics Services (NGS), CSIR - Centre For Cellular And Molecular BiologyJan 13, 2020The NM_000352.6:c.2522G>A variant is not present in publicly available database, Exome Variant Server (EVS). The variant is present in 1000 Genomes, Exome Aggregation Consortium (ExAC), Genome Aggregation Database (gnomAD) and dbSNP at a very low frequency (MAF<=0.0001) in heterozygous state. The variant is not present in our in-house exome database. The variant was earlier reported to Human Genome Mutation database (HGMD ID: CM112697) in other similarly affected individuals [Banerjee et al., Eur J Endocrinol 2011]. In-silico pathogenicity prediction programs like SIFT, Polyphen2, MutationTaster2, CADD etc. predicted this variant as likely deleterious. Hence as per ACMG guidelines the variant has been classified as likely pathogenic. -
Uncertain significance, flagged submissionclinical testingCounsylSep 26, 2017- -
Likely pathogenic, criteria provided, single submitterclinical testingInstitute of Human Genetics, University of Leipzig Medical CenterJan 01, 2019- -
Type 2 diabetes mellitus Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsMay 20, 2023- -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpMay 13, 2022This missense change has been observed in individuals with clinical features of autosomal recessive diffuse or paternally inherited focal hyperinsulinism (PMID: 21378087, 24686051). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 841 of the ABCC8 protein (p.Arg841Gln). This variant is not present in population databases (gnomAD no frequency). This variant is also known as c.2525G>A p.Arg842Gln. ClinVar contains an entry for this variant (Variation ID: 554121). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCC8 protein function. This variant disrupts the p.Arg841 amino acid residue in ABCC8. Other variant(s) that disrupt this residue have been observed in individuals with ABCC8-related conditions (PMID: 11395395, 32202736), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Neonatal diabetes mellitus Other:1
Uncertain risk allele, criteria provided, single submitterresearchClinical Genomics, Uppaluri K&H Personalized Medicine ClinicMay 27, 2024This variant is found to be a potent moderate impact, variant with a CADD score of 29.8 and sufficient scientific evidence of gene-disease correlation. However, since this is not a high impact variant and no variant evidence, this variant is reclassified as Uncertain risk allele. -
Maturity onset diabetes mellitus in young Other:1
Uncertain risk allele, criteria provided, single submitterresearchClinical Genomics, Uppaluri K&H Personalized Medicine ClinicMay 29, 2024Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant ( rs547150342) in MODY yet. This variant is found to be a potent moderate impact, deleterious variant with a CADD score of 29.8 and sufficient scientific evidence to support gene-disease correlation. However, since this is not a high impact variant and has no variant evidence, this variant is reclassified as Uncertain Risk Allele -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.92
BayesDel_addAF
Pathogenic
0.52
D
BayesDel_noAF
Pathogenic
0.51
CADD
Pathogenic
33
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.95
.;.;D;.;.;.;.;.
Eigen
Pathogenic
0.99
Eigen_PC
Pathogenic
0.94
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
1.0
D;.;D;D;D;D;D;D
M_CAP
Pathogenic
0.76
D
MetaRNN
Pathogenic
0.99
D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.1
.;.;M;.;.;.;.;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-3.6
.;.;D;D;.;.;.;.
REVEL
Pathogenic
0.97
Sift
Uncertain
0.0020
.;.;D;D;.;.;.;.
Sift4G
Uncertain
0.0020
.;.;D;D;.;.;.;.
Polyphen
0.99
.;.;D;.;.;.;.;.
Vest4
0.97, 0.97
MutPred
0.99
.;.;Loss of MoRF binding (P = 0.0178);.;.;.;Loss of MoRF binding (P = 0.0178);.;
MVP
0.98
MPC
0.97
ClinPred
0.99
D
GERP RS
5.8
Varity_R
0.97
gMVP
0.93

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs547150342; hg19: chr11-17434247; COSMIC: COSV105132390; API